Breaking News Instant updates and real-time market news.

2021-01-27 08:05:49 TSQ Townsquare Media $8.80 / +0.05 (+0.57%) 08:05 01/27/21 01/27 08:05 01/27/21 08:05	Townsquare Media upgraded to Outperform from Market Perform at Barrington Barrington analyst James Goss upgraded Townsquare Media to Outperform from Market Perform with a $15 price target. The analyst remains constructive on "many operational and strategic characteristics" of Townsquare, especially its two digital businesses, Townsquare Interactive and Townsquare Ignite, that he says are closing in on a combined revenue contribution of nearly half of the corporate total. Goss believes the value per share "will be adjusted significantly higher" to reflect the "very accretive" buyback of Oaktree's commanding position at a discount to current share prices.
TSQ Townsquare Media $8.80 / +0.05 (+0.57%) 12/16/20 Noble Capital Townsquare Media price target raised to $12 from $8 at Noble Capital 04/14/20 Barrington Townsquare Media downgraded to Market Perform at Barrington 04/14/20 Barrington Townsquare Media downgraded to Market Perform from Outperform at Barrington

2021-01-27 08:05:49

TSQ

Townsquare Media

$8.80 / +0.05 (+0.57%)

08:05

01/27/21

01/27

08:05

01/27/21

08:05

Townsquare Media upgraded to Outperform from Market Perform at Barrington

Barrington analyst James Goss upgraded Townsquare Media to Outperform from Market Perform with a $15 price target. The analyst remains constructive on "many operational and strategic characteristics" of Townsquare, especially its two digital businesses, Townsquare Interactive and Townsquare Ignite, that he says are closing in on a combined revenue contribution of nearly half of the corporate total. Goss believes the value per share "will be adjusted significantly higher" to reflect the "very accretive" buyback of Oaktree's commanding position at a discount to current share prices.

TSQ Townsquare Media

$8.80 / +0.05 (+0.57%)

12/16/20 Noble Capital: Townsquare Media price target raised to $12 from $8 at Noble Capital

04/14/20 Barrington: Townsquare Media downgraded to Market Perform at Barrington

04/14/20 Barrington: Townsquare Media downgraded to Market Perform from Outperform at Barrington

TODAY'S FREE FLY STORIES

Conference/Events	Pool Corp. management to meet virtually with Sidoti » 10:34 03/01/21 03/01 10:34 03/01/21 10:34 POOL Pool Corp. $335.82 / +0.8 (+0.24%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events Options POOL Pool Corp. $335.82 / +0.8 (+0.24%) 12/27/20 Fly Intel: Top five weekend stock stories 10/07/20 Neogen to replace Pool Corp. in S&P 400 at open on 10/7 10/07/20 Pool Corp. to replace E-Trade in S&P 500 at open on 10/7 10/01/20 Neogen to replace Pool Corp. in S&P 400 at open on 10/7 POOL Pool Corp. $335.82 / +0.8 (+0.24%) 02/10/21 Berenberg Leslie's initiated with a Hold at Berenberg 01/15/21 Jefferies Pool Corp. price target raised to $400 from $350 at Jefferies 12/31/20 William Blair Azek, Trex among Blair's top Specialty Distribution ideas for 2021 11/11/20 Stephens Pool Corp. resumed with an Equal Weight at Stephens POOL Pool Corp. $335.82 / +0.8 (+0.24%) 02/11/21 Pool Corp. reports 2021 EPS $9.12-$9.62, consensus $9.25 02/11/21 Pool Corp. reports Q4 EPS ($1.45), consensus 76c 10/22/20 Pool Corp. raises FY20 EPS ex-items view $8.20-$8.50 from $7.05-$7.45 10/22/20 Pool Corp. reports Q3 EPS $2.92, consensus $2.18 POOL Pool Corp. $335.82 / +0.8 (+0.24%) 12/26/20 Pool Corp. got COVID boost, still a Buy, Barron's says 03/04/21 Pool Corp. POOL Pool Corp. $335.82 / +0.8 (+0.24%) 02/12/21 Early notable gainers among liquid option names on February 12th
Conference/Events	AMN Healthcare management to meet virtually with Sidoti » 10:33 03/01/21 03/01 10:33 03/01/21 10:33 AMN AMN Healthcare $73.85 / +0.96 (+1.32%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events AMN AMN Healthcare $73.85 / +0.96 (+1.32%) 02/22/21 BMO Capital AMN Healthcare price target raised to $86 from $81 at BMO Capital 02/19/21 Truist AMN Healthcare price target raised to $95 from $84 at Truist 01/20/21 Truist AMN Healthcare price target raised to $84 from $78 at Truist 01/19/21 BMO Capital AMN Healthcare price target raised to $81 from $72 at BMO Capital AMN AMN Healthcare $73.85 / +0.96 (+1.32%) 02/18/21 AMN Healthcare sees Q1 revenue $800M-$820M, consensus $605.28M 02/18/21 AMN Healthcare reports Q4 adjusted EPS $1.00, consensus 89c 01/11/21 AMN Healthcare sees Q4 revenue $623M-$628M, consensus $584.45M 11/05/20 AMN Healthcare sees Q4 revenue $575M-$585M, consensus $549.71M 03/16/21 31st Annual Healthcare Virtual Conference 03/29/21 AMN Healthcare - AMN 03/03/21 AMN Healthcare
Recommendations	InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright » 10:32 03/01/21 03/01 10:32 03/01/21 10:32 ATXI Avenue Therapeutics $5.00 / +0.29 (+6.16%) After Avenue Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events ATXI Avenue Therapeutics $5.00 / +0.29 (+6.16%) 10:28 Today Avenue Therapeutics reports PDUFA date of April 12, 2021 set for IV Tramadol 02/17/21 Avenue Therapeutics resubmitted New Drug Application for IV tramadol 12/18/20 Avenue Therapeutics announces publication on teal-world data on NMU of tramadol 12/18/20 Avenue Therapeutics announces publication on tramadol non-medical use ATXI Avenue Therapeutics $5.00 / +0.29 (+6.16%) 02/17/21 Dawson James Fortress Biotech price target raised to $21 from $16 at Dawson James 10/12/20 H.C. Wainwright Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright 10/12/20 H.C. Wainwright Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 10/12/20 H.C. Wainwright H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL ATXI Avenue Therapeutics $5.00 / +0.29 (+6.16%) 10/12/20 Fly Intel: Wall Street's top stories for Monday 10/12/20 Fly Intel: Wall Street's top stories at midday 10/12/20 Fly Intel: Pre-market Movers 03/16/21 31st Annual Healthcare Virtual Conference
Hot Stocks	FedEx begins shipping newly approved Covid vaccine on behalf of McKesson » 10:30 03/01/21 03/01 10:30 03/01/21 10:30 FDX FedEx $259.43 / +4.4 (+1.73%) , MCK McKesson $172.80 / +3.99 (+2.36%) FedEx Express, a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FDX MCK FDX FedEx $259.43 / +4.4 (+1.73%) 01/26/21 FedEx Ground CEO Maier to retire July 31, John Smith to succeed 01/19/21 FedEx Express plans to cut 5,500-6,300 jobs in Europe 12/20/20 Fly Intel: Top five weekend stock stories 12/20/20 FedEx to ship first wave of Moderna COVID-19 vaccines across the U.S. MCK McKesson $172.80 / +3.99 (+2.36%) 12/20/20 Fly Intel: Top five weekend stock stories 12/20/20 FedEx to ship first wave of Moderna COVID-19 vaccines across the U.S. 12/04/20 McKesson, Amgen sign strategic agreement to help improve cancer care 11/19/20 McKesson names Dr. Kevin Baggett as Chief Impact Officer FDX MCK FDX FedEx $259.43 / +4.4 (+1.73%) 01/07/21 Wolfe Research FedEx downgraded to Peer Perform from Outperform at Wolfe Research 12/30/20 Argus FedEx price target raised to $305 from $270 at Argus 12/18/20 Raymond James FedEx price target raised to $305 from $280 at Raymond James 12/18/20 Morgan Stanley FedEx's 'modest' Q2 beat likely falls short of high bar, says Morgan Stanley MCK McKesson $172.80 / +3.99 (+2.36%) 02/03/21 Credit Suisse McKesson price target raised to $192 from $178 at Credit Suisse 02/03/21 Deutsche Bank McKesson price target raised to $231 from $222 at Deutsche Bank 02/03/21 Mizuho McKesson price target raised to $190 from $178 at Mizuho 02/01/21 Cowen McKesson price target raised to $210 from $186 at Cowen FDX MCK FDX FedEx $259.43 / +4.4 (+1.73%) 12/17/20 FedEx aims to increase EPS by 10%-15 per year over long term 12/17/20 FedEx reports Q2 EPS $4.83, consensus $4.01 12/17/20 Notable companies reporting after market close 09/15/20 FedEx reports Q1 adjusted EPS $4.87, consensus $2.69 MCK McKesson $172.80 / +3.99 (+2.36%) 02/02/21 McKesson raises FY21 adjusted EPS view to $16.95-$17.25 from $16.00-$16.50 02/02/21 McKesson reports Q3 adjusted EPS $4.60, consensus $4.13 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open FDX MCK FDX FedEx $259.43 / +4.4 (+1.73%) 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports 11/25/20 FedEx, UPS run into shortage of vans amid delivery rush, Bloomberg reports 11/10/20 Amazon moving into middle-mile trucking business, The Information reports 10/19/20 FedEx, UPS holiday capacity 'already spoken for,' WSJ reports MCK McKesson $172.80 / +3.99 (+2.36%) 02/16/21 McKesson in talks to sell LloydsPharmacy chain, Sky News reports 01/20/21 McKesson to replace some Moderna vaccine shots shipped too cold, Bloomberg says 11/05/20 Distributors and J&J closing in on $26B opioid settlement deal, NY Times says 09/24/20 U.S. appeals court rejects novel opioid settlement framework, Reuters says FDX MCK FDX FedEx $259.43 / +4.4 (+1.73%) 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 12/18/20 Fly Intel: Pre-market Movers MCK McKesson $172.80 / +3.99 (+2.36%) 02/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/02/21 Fly Intel: Wall Street's top stories at midday 02/02/21 Fly Intel: Pre-market Movers 11/24/20 Fly Intel: Wall Street's top stories at midday 03/02/21 41st Annual Healthcare Virtual Conference 03/18/21 FedEx - FDX FDX MCK FDX FedEx $259.43 / +4.4 (+1.73%) 02/05/21 Unusually active option classes on open February 5th 12/17/20 Fedex options imply 9.8% move in share price post-earnings 09/24/20 Unusual call flow in option market yesterday 09/23/20 Fedex puts deliver express profits as shares tumble $6 MCK McKesson $172.80 / +3.99 (+2.36%) 11/03/20 Early notable gainers among liquid option names on November 3rd
General news	Treasury Action: yields are mixed despite a hefty rally on Wall Street » 10:30 03/01/21 03/01 10:30 03/01/21 10:30 Treasury Action: yields… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Hot Stocks	Avenue Therapeutics reports PDUFA date of April 12, 2021 set for IV Tramadol » 10:28 03/01/21 03/01 10:28 03/01/21 10:28 ATXI Avenue Therapeutics $5.00 / +0.29 (+6.16%) In a regulatory filing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events ATXI Avenue Therapeutics $5.00 / +0.29 (+6.16%) 02/17/21 Avenue Therapeutics resubmitted New Drug Application for IV tramadol 12/18/20 Avenue Therapeutics announces publication on teal-world data on NMU of tramadol 12/18/20 Avenue Therapeutics announces publication on tramadol non-medical use 12/17/20 Avenue Therapeutics plans to resubmit NDA for IV tramadol in February 2021 ATXI Avenue Therapeutics $5.00 / +0.29 (+6.16%) 02/17/21 Dawson James Fortress Biotech price target raised to $21 from $16 at Dawson James 10/12/20 H.C. Wainwright Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright 10/12/20 H.C. Wainwright Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 10/12/20 H.C. Wainwright H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL ATXI Avenue Therapeutics $5.00 / +0.29 (+6.16%) 10/12/20 Fly Intel: Wall Street's top stories for Monday 10/12/20 Fly Intel: Wall Street's top stories at midday 10/12/20 Fly Intel: Pre-market Movers 03/16/21 31st Annual Healthcare Virtual Conference
Conference/Events	Jones Lang LaSalle participates in a conference call with BMO Capital » 10:27 03/01/21 03/01 10:27 03/01/21 10:27 JLL Jones Lang LaSalle $178.25 / +3.765 (+2.16%) Conference call with Bob… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events JLL Jones Lang LaSalle $178.25 / +3.765 (+2.16%) 02/17/21 JLL appoints Gilda Perez-Alvarado as global CEO, Hotels & Hospitality 01/25/21 JLL appoints Ingrid Jacobs as head of diversity, inclusion 11/24/20 BP, Jones Lang LaSalle enter multi-year vested workplace evolution agreement 11/20/20 JLL names Rastogi chief product officer to lead JLL Technologies JLL Jones Lang LaSalle $178.25 / +3.765 (+2.16%) 02/26/21 JPMorgan Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan 01/25/21 Goldman Sachs Jones Lang LaSalle initiated with a Buy at Goldman Sachs 12/21/20 JPMorgan Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan 10/07/20 Keefe Bruyette Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette JLL Jones Lang LaSalle $178.25 / +3.765 (+2.16%) 02/09/21 Jones Lang LaSalle reports Q4 adjusted EPS $5.29 vs. $6.35 a year ago 02/09/21 Jones Lang LaSalle reports Q4 adjusted EPS $5.29, consensus $3.93 11/02/20 Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25 11/02/20 Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25 00:00 Today 42nd Annual Institutional Investors Virtual Conference 03/03/21 Jones Lang LaSalle - JLL
Options	Macy's call volume above normal and directionally bullish » 10:25 03/01/21 03/01 10:25 03/01/21 10:25 M Macy's $16.06 / +0.86 (+5.66%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options M Macy's $16.06 / +0.86 (+5.66%) 02/23/21 Macy's starting the year with 'really healthy' inventory 02/23/21 Macy's sees 1H21 'very similar' to 4Q20 02/23/21 Macy's testing off-mall concepts in Dallas, Atlanta, Washington DC 02/23/21 Macy's to open more Backstage discount concepts in 2021 M Macy's $16.06 / +0.86 (+5.66%) 02/24/21 Credit Suisse Macy's price target raised to $13 from $7 at Credit Suisse 02/24/21 Deutsche Bank Macy's price target raised to $16 from $15 at Deutsche Bank 02/18/21 Morgan Stanley Macy's price target raised to $11 from $6 at Morgan Stanley 01/21/21 Deutsche Bank Macy's price target raised to $15 from $9 at Deutsche Bank M Macy's $16.06 / +0.86 (+5.66%) 02/23/21 Macy's sees Q1 adjusted EPS (52c)-(45c), consensus (29c) 02/23/21 Macy's sees FY21 adjusted EPS 40c-90c, consensus 76c 02/23/21 Macy's reports Q4 adjusted EPS 80c, consensus 12c 02/22/21 Notable companies reporting before tomorrow's open M Macy's $16.06 / +0.86 (+5.66%) 02/28/21 Macy's, Gap letting customers buy now, pay later, WSJ reports 01/05/21 Macy's to close 45 department stores by mid-year, CNBC reports 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports 10/14/20 Macy's converts two stores to fulfillment centers, Delaware News says M Macy's $16.06 / +0.86 (+5.66%) 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 Fly Intel: Pre-market Movers 12/18/20 Fly Intel: What to watch in Nike's earnings report M Macy's $16.06 / +0.86 (+5.66%) 01/28/21 Macy's call volume above normal and directionally bullish 01/28/21 Early notable gainers among liquid option names on January 28th 01/27/21 Early notable gainers among liquid option names on January 27th 01/25/21 Macy's call volume above normal and directionally bullish
Conference/Events	UBS consumer goods analysts to hold an analyst/industry conference call » 10:25 03/01/21 03/01 10:25 03/01/21 10:25 Consumer Goods Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Vocera to hold virtual investor briefing » 10:25 03/01/21 03/01 10:25 03/01/21 10:25 VCRA Vocera $44.04 / +1.1 (+2.56%) Virtual Investor Briefing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VCRA Vocera $44.04 / +1.1 (+2.56%) 02/10/21 Vocera falls -10.8% 01/29/21 Vocera CFO Justin Spencer to leave in June 12/18/20 Vocera rises 10.6% VCRA Vocera $44.04 / +1.1 (+2.56%) 02/12/21 Piper Sandler Piper boosts Vocera target to $56, says buy into March 1 investor day 02/12/21 Baird Vocera upgraded to Outperform from Neutral at Baird 02/12/21 Craig-Hallum Vocera price target raised to $50 from $40 at Craig-Hallum 02/12/21 William Blair Vocera has good visibility into 'solid' 2021, says William Blair VCRA Vocera $44.04 / +1.1 (+2.56%) 02/11/21 Vocera sees FY21 adjusted EPS 45c-61c, consensus 59c 02/11/21 Vocera reports Q4 adjusted EPS 28c, consensus 20c 10/29/20 Vocera reports Q3 EPS 31c, consensus 13c VCRA Vocera $44.04 / +1.1 (+2.56%) 02/11/21 Fly Intel: After-Hours Movers 11:00 Today Vocera Communications Inc

Conference/Events	e.l.f. Beauty participates in a conference call with JPMorgan » 10:25 03/01/21 03/01 10:25 03/01/21 10:25 ELF e.l.f. Beauty $26.45 / +0.73 (+2.84%) Beverage, Household &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ELF e.l.f. Beauty $26.45 / +0.73 (+2.84%) 02/23/21 GameStop announces resignation of CFO Jim Bell 02/03/21 e.l.f. Beauty CEO: We're really pleased with the quarter 01/22/21 e.l.f. Beauty CEO sells 34.6K shares of common stock 01/07/21 e.l.f. Beauty to replace Brooks Automation in the S&P 600 at open on January 7 ELF e.l.f. Beauty $26.45 / +0.73 (+2.84%) 02/04/21 e.l.f. Beauty price target raised to $30 from $25 at Truist 01/20/21 Piper Sandler e.l.f. Beauty downgraded to Neutral from Overweight at Piper Sandler 10/06/20 Piper Sandler Piper teen survey shows Snap, Amazon and Apple remain favorites 08/06/20 Truist e.l.f. Beauty price target raised to $25 from $20 at Truist ELF e.l.f. Beauty $26.45 / +0.73 (+2.84%) 02/03/21 e.l.f. Beauty raises FY21 EPS view to 63c-64c from 59c-63c 02/03/21 e.l.f. Beauty reports Q3 adjusted EPS 22c, consensus 24c 02/03/21 Notable companies reporting after market close 11/04/20 e.l.f. Beauty sees FY22-FY24 net sales up mid-high single digits ELF e.l.f. Beauty $26.45 / +0.73 (+2.84%) 02/03/21 Fly Intel: After-Hours Movers 12/30/20 Fly Intel: After-Hours Movers 11/04/20 Fly Intel: After-Hours Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 11:00 Today e.l.f. Beauty - ELF
Conference/Events	JPMorgan transports/logistics analyst to hold analyst/industry conference call » 10:25 03/01/21 03/01 10:25 03/01/21 10:25 Transports &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	UBS technology analyst to hold lan analyst/industry conference call » 10:25 03/01/21 03/01 10:25 03/01/21 10:25 Technology Analyst Arcuri… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Upgrade	BYD upgraded to Buy from Neutral at Goldman Sachs » 10:22 03/01/21 03/01 10:22 03/01/21 10:22 BYDDF BYD $0.00 / + (+0.00%) Goldman Sachs analyst Fei… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BYDDF BYD $0.00 / + (+0.00%) 11/09/20 JPMorgan BYD downgraded to Neutral from Overweight at JPMorgan 09/01/20 Jefferies BYD upgraded to Buy from Hold at Jefferies 06/04/20 JPMorgan BYD upgraded to Overweight from Underweight at JPMorgan 04/29/20 Jefferies BYD A shares upgraded to Buy from Hold at Jefferies
Conference/Events	The Genome Partnership to hold a virtual meeting » 10:21 03/01/21 03/01 10:21 03/01/21 10:21 NSTG NanoString $71.00 / +0.98 (+1.40%) , TWST Twist Bioscience $149.86 / +12.12 (+8.80%) , PACB Pacific Biosciences $34.91 / +4.34 (+14.20%) , QGEN Qiagen $49.89 / -0.16 (-0.32%) , TXG 10x Genomics $179.29 / +1.32 (+0.74%) , CDXS Codexis $23.24 / +1.06 (+4.78%) , PKI PerkinElmer $128.65 / +2.46 (+1.95%) , ILMN Illumina $447.82 / +8.24 (+1.87%) , RHHBY Roche $0.00 / + (+0.00%) , BNGO Bionano Genomics $10.01 / +0.275 (+2.82%) Advances in Genome… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options NSTG TWST PACB QGEN TXG CDXS PKI ILMN RHHBY BNGO NSTG NanoString $71.00 / +0.98 (+1.40%) 02/22/21 NanoString announces launch of Whole Transcriptome Atlas 11/17/20 NanoString, OHSU partner on GeoMx-based spatial profiling assays 09/09/20 NanoString announces new GeoMx COVID-19 consortium TWST Twist Bioscience $149.86 / +12.12 (+8.80%) 02/18/21 Twist Bioscience and VCGS in development pact for diagnostic assay 02/03/21 Twist Bioscience announces promotions including Siyuan Chen as CTO 01/19/21 Twist Bioscience enters two licensing agreements with Serotiny, Applied StemCell 01/14/21 Twist Bioscience begins shipping new synthetic RNA reference controls PACB Pacific Biosciences $34.91 / +4.34 (+14.20%) 02/24/21 Children's Mercy Kansas City implements four PacBio Sequel IIe Systems 02/18/21 Pacific Biosciences announces LabCorp's addition of PacBio Sequel II Systems 02/10/21 Pacific Biosciences reports Q4 EPS 40c, consensus 32c 02/10/21 Pacific Biosciences announces $900M investment from SoftBank QGEN Qiagen $49.89 / -0.16 (-0.32%) 02/24/21 Qiagen, Inovio expand collaboration to develop NGS companion diagnostic 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/10/21 Qiagen CEO says will consider potential 'bolt-on acquisitions' 02/09/21 Quidel CEO tells Bloomberg won't enter deal without 'obvious strategic fit' TXG 10x Genomics $179.29 / +1.32 (+0.74%) 02/16/21 Third Point buys Upstart, exits Caesars in Q4 10/05/20 10x Genomics acquires ReadCoor for $350M 09/15/20 10x Genomics shipping Chromium Single Cell Multiome ATAC + Gene Expression CDXS Codexis $23.24 / +1.06 (+4.78%) 01/13/21 Codexis, Tate & Lyle expand relationship to enhance stevia, allulose production PKI PerkinElmer $128.65 / +2.46 (+1.95%) 02/23/21 PerkinElmer launches point of care Covid-19 antigen test for mass screening 02/22/21 PerkinElmer gives update on Valencia Branch Laboratory's accreditation process 02/16/21 Organogenesis appoints David Francisco as CFO 01/14/21 PerkinElmer SARS-CoV-2 RT-PCR assay receives FDA EUA for asymptomatic testing ILMN Illumina $447.82 / +8.24 (+1.87%) 02/19/21 Illumina, University Hospital of Tubingen to evaluate WGS potential 02/08/21 Illumina accelerator invests in nine genomics startups for second global cycle 02/04/21 Illumina announces agreement with Belgian Society of Medical Oncology 01/20/21 Illumina wins patent infringement suit against BGI in U.K. RHHBY Roche $0.00 / + (+0.00%) 02/26/21 Regeneron announces CHMP recommendation for COVID-19 antibody cocktail 02/24/21 Prothena announces presentation of new preclinical PRX005 data 02/19/21 Atea Pharmaceuticals announces Chugai in-license of AT-527 from Roche 02/12/21 Genentech announces results from four Phase III studies of faricimab BNGO Bionano Genomics $10.01 / +0.275 (+2.82%) 02/22/21 Bionano Genomics announces publication on genome-wide model 02/11/21 Bionano Genomics announces publication on method for optical genome mapping 02/09/21 Bionano Genomics' Saphyr adopted by Canada's largest hospital diagnostic lab 02/02/21 Bionano Genomics announces publication of study on DNA methylation NSTG TWST PACB QGEN TXG CDXS PKI ILMN RHHBY BNGO NSTG NanoString $71.00 / +0.98 (+1.40%) 01/11/21 Baird NanoString price target raised to $70 from $60 at Baird 01/06/21 Cowen NanoString upgraded to Outperform with $75 target at Cowen 01/06/21 Cowen NanoString upgraded to Outperform from Market Perform at Cowen 12/02/20 JPMorgan NanoString price target raised to $60 from $45 at JPMorgan TWST Twist Bioscience $149.86 / +12.12 (+8.80%) 02/05/21 Baird Twist Bioscience price target raised to $200 from $125 at Baird 02/05/21 JPMorgan Twist Bioscience downgraded to Underweight from Neutral at JPMorgan 01/04/21 Evercore ISI Evercore ISI cuts Twist Bioscience to In Line, says new verticals take time 01/04/21 Evercore ISI Twist Bioscience downgraded to In Line from Outperform at Evercore ISI PACB Pacific Biosciences $34.91 / +4.34 (+14.20%) 02/11/21 Cantor Fitzgerald Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald 02/11/21 Piper Sandler Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler 01/15/21 Piper Sandler Pacific Biosciences price target raised to $20 from $12 at Piper Sandler 01/12/21 Cantor Fitzgerald Pacific Biosciences price target raised to $45 from $25 at Cantor Fitzgerald QGEN Qiagen $49.89 / -0.16 (-0.32%) 02/19/21 Berenberg Qiagen price target raised to EUR 56 from EUR 52 at Berenberg 02/09/21 William Blair Quidel, Qiagen merger would not make sense, says William Blair 02/09/21 Wells Fargo Qiagen shares should be sold on latest merger talk, says Wells Fargo 02/09/21 Citi Merger with Qiagen would benefit Quidel, says Citi TXG 10x Genomics $179.29 / +1.32 (+0.74%) 02/18/21 Cowen 10x Genomics price target raised to $200 from $155 at Cowen 02/18/21 JPMorgan 10x Genomics price target raised to $195 from $160 at JPMorgan 02/18/21 Citi 10x Genomics price target raised to $240 from $195 at Citi 12/16/20 Citi 10x Genomics price target raised to $195 from $165 at Citi CDXS Codexis $23.24 / +1.06 (+4.78%) 06:53 Today Stifel Codexis initiated with a Buy at Stifel 12/30/20 Benchmark Codexis price target raised to $29 from $21 at Benchmark 07/15/20 Stephens Codexis resumed with an Overweight at Stephens 03/10/20 Benchmark Codexis initiated with a Buy at Benchmark PKI PerkinElmer $128.65 / +2.46 (+1.95%) 02/03/21 Citi PerkinElmer price target raised to $155 from $150 at Citi 01/07/21 Piper Sandler Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo ILMN Illumina $447.82 / +8.24 (+1.87%) 02/16/21 BTIG Illumina price target raised to $570 from $410 at BTIG 02/12/21 Piper Sandler Illumina price target raised to $510 from $415 at Piper Sandler 02/12/21 Cowen Illumina price target raised to $460 from $385 at Cowen 12/22/20 Fly Intel: Top five analyst upgrades RHHBY Roche $0.00 / + (+0.00%) 02/25/21 Berenberg Roche price target lowered to CHF 320 from CHF 325 at Berenberg 02/24/21 Morgan Stanley Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/17/21 UBS UBS downgrades Roche to Neutral on risk to 2022 estimates BNGO Bionano Genomics $10.01 / +0.275 (+2.82%) 02/08/21 Oppenheimer Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer 01/26/21 Ladenburg Bionano Genomics price target raised to $14 from $1.25 at Ladenburg 01/22/21 Maxim Bionano Genomics price target raised to $14 from $2 at Maxim 12/04/20 Roth Capital Bionano Genomics downgraded to Neutral from Buy at Roth Capital NSTG TWST PACB QGEN TXG CDXS PKI ILMN RHHBY BNGO NSTG NanoString $71.00 / +0.98 (+1.40%) 01/10/21 NanoString sees Q4 product/service revenue $35.7M, consensus $33.36M 11/09/20 NanoString reports Q3 EPS (56c), consensus (60c) 10/06/20 NanoString sees Q3 product/service revenue $30.1M, consensus $27.19M TWST Twist Bioscience $149.86 / +12.12 (+8.80%) 02/04/21 Twist Bioscience backs FY21 revenue view $110M-$118M, consensus $116.02M 02/04/21 Twist Bioscience reports Q1 EPS (72c), consensus (74c) 11/23/20 Twist Bioscience sees Q1 revenue $25M-$26M 11/23/20 Twist Bioscience sees FY21 revenue $110M-$118M, consensus $117.9M PACB Pacific Biosciences $34.91 / +4.34 (+14.20%) 01/11/21 Pacific Biosciences sees Q4 revenue $27M, consensus $23.69M 11/02/20 Pacific Biosciences reports Q3 EPS (14c), consensus (13c) QGEN Qiagen $49.89 / -0.16 (-0.32%) 02/09/21 Qiagen backs FY21 EPS view $2.42-$2.46, consensus $2.40 02/09/21 Qiagen reports Q4 EPS 68c, consensus 65c 12/08/20 Qiagen sees FY21 adj. EPS $2.42-$2.46 CER, consensus $2.40 12/08/20 Qiagen raises FY20 adj. EPS view to $2.13-$2.14 CER from $2.07-$2.09 CER TXG 10x Genomics $179.29 / +1.32 (+0.74%) 02/17/21 10x Genomics sees FY21 revenue $480M-$500M, consensus $494.02M 02/17/21 10x Genomics reports Q4 EPS ($3.87), consensus (23c) 11/10/20 10x Genomics reports Q3 EPS (65c), consensus (30c) CDXS Codexis $23.24 / +1.06 (+4.78%) 02/25/21 Codexis sees FY21 revenue $82M-$85M, consensus $80.53M 02/25/21 Codexis reports Q4 EPS (6c), consensus (12c) 11/05/20 Codexis reports Q3 EPS (10c), consensus (11c) PKI PerkinElmer $128.65 / +2.46 (+1.95%) 02/02/21 PerkinElmer sees Q1 adjusted EPS of at least $3.00, consensus $2.40 02/02/21 PerkinElmer sees FY21 adjusted EPS at least $8.50, consensus $8.88 02/02/21 PerkinElmer reports Q4 adjusted EPS $3.96, consensus $3.00 01/11/21 PerkinElmer sees Q4 adjusted EPS 'at least' $3.60, consensus $2.79 ILMN Illumina $447.82 / +8.24 (+1.87%) 02/11/21 Illumina sees FY21 adjusted EPS $5.10-$5.35, consensus $6.11 02/11/21 Illumina reports Q4 adjusted EPS $1.22, consensus $1.11 02/11/21 Notable companies reporting after market close 01/11/21 Illumina sees FY21 adjusted EPS $5.10-$5.35, consensus $6.61 RHHBY Roche $0.00 / + (+0.00%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year BNGO Bionano Genomics $10.01 / +0.275 (+2.82%) 11/12/20 Bionano Genomics reports Q3 revenue $2.2M, consensus $2.07M. 10/15/20 Bionano Genomics sees Q3 revenue $1.9M-$2.3M, consensus $2.07M 20 Jan 08 Jan 03 Dec 03 Dec 11 Nov 08 Oct 11 Sep 12 Aug 04 Jun PACB QGEN ILMN RHHBY PACB Pacific Biosciences $34.91 / +4.34 (+14.20%) 02/23/21 Sources claim Softbank plans 'billions' in investment in biotech, Bloomberg says 02/10/21 SoftBank to invest $900M in Pacific Biosciences, WSJ reports 01/08/21 SoftBank has taken 6% stake in Pacific Biosciences, Bloomberg reports 01/08/21 Pacific Biosciences jumps after Bloomberg says SoftBank takes 6% stake QGEN Qiagen $49.89 / -0.16 (-0.32%) 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports 02/08/21 Qiagen jumps after Bloomberg says Quidel made preliminary approach 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports ILMN Illumina $447.82 / +8.24 (+1.87%) 09/16/20 Illumina near deal to acquire cancer testing company Grail, Bloomberg reports RHHBY Roche $0.00 / + (+0.00%) 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports NSTG TWST PACB QGEN TXG CDXS PKI ILMN RHHBY BNGO NSTG NanoString $71.00 / +0.98 (+1.40%) 10/06/20 Fly Intel: After-Hours Movers TWST Twist Bioscience $149.86 / +12.12 (+8.80%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 12/01/20 Fly Intel: After-Hours Movers 11/23/20 Fly Intel: Pre-market Movers PACB Pacific Biosciences $34.91 / +4.34 (+14.20%) 11/03/20 Fly Intel: Pre-market Movers 10/02/20 Fly Intel: Pre-market Movers QGEN Qiagen $49.89 / -0.16 (-0.32%) 02/09/21 Fly Intel: After-Hours Movers 02/08/21 Fly Intel: Wall Street's top stories for Monday 11/11/20 Fly Intel: After-Hours Movers TXG 10x Genomics $179.29 / +1.32 (+0.74%) 10/05/20 Fly Intel: After-Hours Movers 09/08/20 Fly Intel: After-Hours Movers CDXS Codexis $23.24 / +1.06 (+4.78%) 12/03/20 Fly Intel: Wall Street's top stories for Thursday 12/03/20 Fly Intel: Wall Street's top stories at midday 12/03/20 Fly Intel: Pre-market Movers PKI PerkinElmer $128.65 / +2.46 (+1.95%) 01/07/21 Fly Intel: Pre-market Movers ILMN Illumina $447.82 / +8.24 (+1.87%) 10/29/20 Fly Intel: After-Hours Movers 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday 09/21/20 Fly Intel: Pre-market Movers RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks BNGO Bionano Genomics $10.01 / +0.275 (+2.82%) 01/19/21 Fly Intel: After-Hours Movers 01/15/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Advances in Genome Biology & Technology: AGBT 2021 Virtual Event 03/02/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 16:30 Today NanoString - NSTG 03/25/21 Roche - RHHBY PACB QGEN PKI ILMN BNGO PACB Pacific Biosciences $34.91 / +4.34 (+14.20%) 01/08/21 Pacific Biosciences call volume above normal and directionally bullish 11/02/20 Pacific Biosciences options imply 18.3% move in share price post-earnings QGEN Qiagen $49.89 / -0.16 (-0.32%) 10/14/20 Call spread buyer crosses wide spread in Qiagen 09/16/20 Largest borrow rate increases among liquid names PKI PerkinElmer $128.65 / +2.46 (+1.95%) 09/11/20 Early notable gainers among liquid option names on September 11th ILMN Illumina $447.82 / +8.24 (+1.87%) 02/12/21 Early notable gainers among liquid option names on February 12th 01/15/21 Early notable gainers among liquid option names on January 15th 12/22/20 Early notable gainers among liquid option names on December 22nd 09/22/20 Illumina call volume above normal and directionally bullish BNGO Bionano Genomics $10.01 / +0.275 (+2.82%) 02/12/21 Bionano Genomics call volume above normal and directionally bullish 02/11/21 Bionano Genomics call volume above normal and directionally bullish 01/26/21 Largest borrow rate increases among liquid names 01/13/21 Thirteen new option listings and two option delistings on January 13th

Downgrade	RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna » 10:21 03/01/21 03/01 10:21 03/01/21 10:21 OTRK Ontrak $32.45 / -26.68 (-45.12%) , CVS CVS Health $68.88 / +0.75 (+1.10%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options OTRK CVS OTRK Ontrak $32.45 / -26.68 (-45.12%) 10/29/20 Ontrak acquires behavior change platform LifeDojo 10/13/20 Ontrak rises after announcing launch of Ontrak-CI program CVS CVS Health $68.88 / +0.75 (+1.10%) 02/24/21 CVS Health to administer COVID-19 vaccines in six additional states 02/18/21 Capital Senior Living completes first round of COVID-19 vaccinations 02/16/21 CVS has capacity to administer 20M-25M Covid vaccines per month 02/16/21 CVS Health sees Q1 as lowest earnings quarter for the year OTRK CVS OTRK Ontrak $32.45 / -26.68 (-45.12%) 10:17 Today RBC Capital Ontrak downgraded to Sector Perform from Outperform at RBC Capital 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/04/21 B. Riley Securities Ontrak price target raised to $110 from $100 at B. Riley Securities 11/18/20 B. Riley Securities Ontrak initiated with a Buy at B. Riley Securities CVS CVS Health $68.88 / +0.75 (+1.10%) 01/29/21 Jefferies Carvana, Walmart among 13 additions to Jefferies Franchise Picks list 01/22/21 Baird Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird 01/19/21 JPMorgan Teladoc remains top 2021 healthcare technology pick at JPMorgan 01/08/21 Fly Intel: Top five analyst upgrades OTRK CVS OTRK Ontrak $32.45 / -26.68 (-45.12%) 08:07 Today Ontrak sees FY21 revenue $100M, consensus $165.05M 08:06 Today Ontrak reports Q4 EPS (7c), consensus (30c) 11/05/20 Ontrak reports Q3 EPS (36c), consensus (35c) CVS CVS Health $68.88 / +0.75 (+1.10%) 02/16/21 CVS Health sees FY21 revenue $276.1B-$280.6B, consensus $278.39B 02/16/21 CVS Health sees FY21 adjusted EPS $7.39-$7.55, consensus $7.54 02/16/21 CVS Health reports Q4 adjusted EPS $1.30, consensus $1.24 11/06/20 CVS Health raises FY20 adj. EPS view to $7.35-$7.45 from $7.14-$7.27 CVS CVS CVS Health $68.88 / +0.75 (+1.10%) 02/14/21 Walmart COVID vaccine rollout heading to small towns, WSJ reports 02/11/21 CVS, Walmart to decide who gets leftover vaccine doses, WSJ reports 01/02/21 Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says 12/20/20 CDC panel says frontline workers, people over 74 should be next, NYTimes reports CVS CVS CVS Health $68.88 / +0.75 (+1.10%) 02/16/21 Fly Intel: Wall Street's top stories at midday 02/16/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: What to watch in Salesforce's earnings report 11/17/20 Fly Intel: Wall Street's top stories at midday 03/02/21 41st Annual Healthcare Virtual Conference 03/09/21 Ontrak - OTRK OTRK CVS OTRK Ontrak $32.45 / -26.68 (-45.12%) 10/12/20 Largest borrow rate increases among liquid names 09/16/20 Ontrak put volume heavy and directionally bearish 09/15/20 Ontrak put volume heavy and directionally bearish CVS CVS Health $68.88 / +0.75 (+1.10%) 02/16/21 Unusually active option classes on open February 16th 01/11/21 CVS Health call volume above normal and directionally bullish 11/17/20 Unusually active option classes on open November 17th 11/10/20 CVS Health call volume above normal and directionally bullish
Recommendations	Homology Medicines loses potential source of upside, says Oppenheimer » 10:18 03/01/21 03/01 10:18 03/01/21 10:18 FIXX Homology Medicines $11.03 / +0.28 (+2.60%) , NVS Novartis $86.59 / +0.57 (+0.66%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FIXX NVS FIXX Homology Medicines $11.03 / +0.28 (+2.60%) 07:50 Today Homology Medicines regains worldwide rights to ophthalmology program 02/08/21 Homology reports first presentation of data from IND-enabling studies of HMI-203 01/12/21 Pfizer invests $120M in four clinical-stage biotech companies 01/06/21 Homology Medicines announces plans for three clinical programs in 2021 NVS Novartis $86.59 / +0.57 (+0.66%) 07:50 Today Homology Medicines regains worldwide rights to ophthalmology program 02/17/21 Novartis announces SCD grant agreement with Bill & Melinda Gates Foundation 02/16/21 Novartis reports Entresto granted expanded indication in chronic heart failure 02/11/21 Novartis' Sandoz agrees to acquire GSK's cephalosporin antibiotics business FIXX NVS FIXX Homology Medicines $11.03 / +0.28 (+2.60%) 12/14/20 H.C. Wainwright Homology Medicines transferred with Buy, $30 target at H.C. Wainwright 11/08/20 Oppenheimer Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer 08/11/20 Oppenheimer Homology Medicines price target lowered to $27 from $32 at Oppenheimer 08/11/20 H.C. Wainwright Homology Medicines price target lowered to $30 from $37 at H.C. Wainwright NVS Novartis $86.59 / +0.57 (+0.66%) 02/02/21 Morgan Stanley Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley 02/01/21 Truist iRhythm price target lowered to $220 from $265 at Truist 02/01/21 Cowen Novartis downgraded to Market Perform after 'tepid' guidance at Cowen 02/01/21 Cowen Novartis downgraded to Market Perform from Outperform at Cowen FIXX NVS FIXX Homology Medicines $11.03 / +0.28 (+2.60%) 11/09/20 Homology Medicines reports Q 3EPS (62c), consensus (80c) NVS Novartis $86.59 / +0.57 (+0.66%) 01/26/21 Novartis sees 2021 core operating income to grow mid single digit 01/26/21 Novartis reports Q4 core EPS $1.34, consensus $1.36 11/05/20 Xoma reports Q3 EPS (10c), consensus (21c) 10/27/20 Novartis raises FY20 core operating income growth outlook NVS NVS Novartis $86.59 / +0.57 (+0.66%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports FIXX NVS FIXX Homology Medicines $11.03 / +0.28 (+2.60%) 11/19/20 Fly Intel: After-Hours Movers NVS Novartis $86.59 / +0.57 (+0.66%) 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 03/02/21 41st Annual Healthcare Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference
Technical Analysis	NASDAQ market internals summary » 10:17 03/01/21 03/01 10:17 03/01/21 10:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 02/26/21 NASDAQ market internals summary 02/26/21 NASDAQ market internals summary 02/26/21 NASDAQ market internals summary 02/26/21 NASDAQ market internals summary
Downgrade	Ontrak downgraded to Sector Perform from Outperform at RBC Capital » 10:17 03/01/21 03/01 10:17 03/01/21 10:17 OTRK Ontrak $32.50 / -26.63 (-45.04%) RBC Capital analyst Sean… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options OTRK Ontrak $32.50 / -26.63 (-45.04%) 10/29/20 Ontrak acquires behavior change platform LifeDojo 10/13/20 Ontrak rises after announcing launch of Ontrak-CI program OTRK Ontrak $32.50 / -26.63 (-45.04%) 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/04/21 B. Riley Securities Ontrak price target raised to $110 from $100 at B. Riley Securities 11/18/20 B. Riley Securities Ontrak initiated with a Buy at B. Riley Securities 10/02/20 Canaccord Ontrak analysis points to significant upside for shares, says Canaccord OTRK Ontrak $32.50 / -26.63 (-45.04%) 08:07 Today Ontrak sees FY21 revenue $100M, consensus $165.05M 08:06 Today Ontrak reports Q4 EPS (7c), consensus (30c) 11/05/20 Ontrak reports Q3 EPS (36c), consensus (35c) 03/02/21 41st Annual Healthcare Virtual Conference 03/09/21 Ontrak - OTRK OTRK Ontrak $32.50 / -26.63 (-45.04%) 10/12/20 Largest borrow rate increases among liquid names 09/16/20 Ontrak put volume heavy and directionally bearish 09/15/20 Ontrak put volume heavy and directionally bearish
Hot Stocks	Workhorse Group has scheduled a face-to-face meeting with USPS on March 3 » 10:16 03/01/21 03/01 10:16 03/01/21 10:16 WKHS Workhorse Group $15.96 / -0.23 (-1.42%) Comments taken from Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WKHS Workhorse Group $15.96 / -0.23 (-1.42%) 09:04 Today Workhorse Group CEO says entering 2021 in 'strongest-ever position' 02/25/21 Workhorse up 20% after congressman vows to fight Oshkosh award from USPS 02/25/21 Workhorse Group trading resumes 02/25/21 Workhorse Group trading halted, volatility trading pause WKHS Workhorse Group $15.96 / -0.23 (-1.42%) 02/24/21 Fly Intel: Top five analyst downgrades 02/24/21 Oppenheimer Opco downgrades Workhorse after Postal Service snub despite backlog 02/24/21 Roth Capital Roth cuts Workhorse target to $15 after 'highly unusual' contract loss 02/24/21 Oppenheimer Workhorse Group downgraded to Perform from Outperform at Oppenheimer WKHS Workhorse Group $15.96 / -0.23 (-1.42%) 09:03 Today Workhorse Group reports Q4 revenue $652,000, consensus $1.32M 11/09/20 Workhorse Group reports Q3 revenue $565,000, consensus $1.81M 11/09/20 Workhorse Group reports Q3 revenue $565,000, consensus $1.81M WKHS Workhorse Group $15.96 / -0.23 (-1.42%) 02/25/21 House Democrat vows to stop USPS contract with Oshkosh, Bloomberg says 02/01/21 Robinhood in talks with lenders to raise $1B in debt, Reuters reports 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 12/02/20 USPS again delays mail truck replacement contract, Trucks.com reports WKHS Workhorse Group $15.96 / -0.23 (-1.42%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/24/21 Workhorse plunges, asks USPS for more info after NGDV deal goes to Oshkosh 10:00 Today Workhorse Group - WKHS WKHS Workhorse Group $15.96 / -0.23 (-1.42%) 02/04/21 Workhorse Group call volume above normal and directionally bullish 01/28/21 Largest borrow rate increases among liquid names 01/26/21 Workhorse Group call volume above normal and directionally bullish 01/26/21 Unusually active option classes on open January 26th

Technical Analysis	NYSE market internals summary » 10:16 03/01/21 03/01 10:16 03/01/21 10:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 02/26/21 NYSE market internals summary 02/26/21 NYSE market internals summary 02/26/21 NYSE market internals summary 02/26/21 NYSE market internals summary
General news	U.S. February ISM manufacturing index increased 2.1 points to 60.8 » 10:15 03/01/21 03/01 10:15 03/01/21 10:15 U.S. February ISM… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	FX Action: The dollar » 10:15 03/01/21 03/01 10:15 03/01/21 10:15 FX Action: The dollar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	U.S. construction spending surged 1.7% in January » 10:15 03/01/21 03/01 10:15 03/01/21 10:15 U.S. construction… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Options	Sallie Mae put volume heavy and directionally bearish » 10:15 03/01/21 03/01 10:15 03/01/21 10:15 SLM Sallie Mae $15.99 / +0.22 (+1.40%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SLM Sallie Mae $15.99 / +0.22 (+1.40%) 02/25/21 Sallie Mae increases price range, extends expiration to buy up to $1B in stock 01/26/21 Sallie Mae names Kerri Palmer Chief Risk and Compliance Officer SLM Sallie Mae $15.99 / +0.22 (+1.40%) 01/29/21 Barclays Sallie Mae price target raised to $18 from $15 at Barclays 01/29/21 RBC Capital Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital 01/29/21 Citi Sallie Mae price target raised to $16 from $12 at Citi 01/29/21 RBC Capital Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital SLM Sallie Mae $15.99 / +0.22 (+1.40%) 01/27/21 Sallie Mae reports Q4 core EPS $1.15, consensus 35c 01/27/21 Notable companies reporting after market close 10/21/20 Sallie Mae reports Q3 core EPS 47c, consensus 8c 10/21/20 Notable companies reporting after market close SLM Sallie Mae $15.99 / +0.22 (+1.40%) 02/22/21 Fly Insider: Corvus, ALJ Regional Holdings among week's notable insider trades 01/27/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers SLM Sallie Mae $15.99 / +0.22 (+1.40%) 01/27/21 Sallie Mae put volume heavy and directionally bearish 12/14/20 Unusual call flow in option market yesterday

Events

Earnings calls, analyst events, roadshows and more

HNI
Today at 11:00

HNI Corporation - HNI Conference Calls
HGV
Today at 11:00

Hilton Grand Vacations - HGV Conference Calls
MIDD
Today at 11:00

Middleby - MIDD Conference Calls
ELF
Today at 11:00

e.l.f. Beauty - ELF Conference Calls
VCRA
Today at 11:00

Vocera Communications Inc Firm Sponsored Meetings

Virtual Meeting
Today at 11:00

Technology Industry Meetings
Today at 11:00

Energy Industry Meetings
Today at 11:00

Transports & Logistics Industry Meetings
Today at 11:00

Consumer Goods Industry Meetings
Today at 11:30

3-Month Bill Auction Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan $124.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Townsquare Media upgraded to Outperform from Market Perform at Barrington

TODAY'S FREE FLY STORIES

Get Full Fly Access